Management and prevention of postoperative Crohn's disease

Gastroenterology and Hepatology

Volumn 7, Issue 3, 2011, Pages 170-172

  Regueiro, Miguel D ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; ADALIMUMAB; ANTIBIOTIC AGENT; AZATHIOPRINE; C REACTIVE PROTEIN; CALGRANULIN; CERTOLIZUMAB PEGOL; INFLIXIMAB; LACTOFERRIN; MERCAPTOPURINE; METRONIDAZOLE; ORNIDAZOLE; TUMOR NECROSIS FACTOR INHIBITOR;

ABSCESS; ANTIBIOTIC THERAPY; CIGARETTE SMOKING; COLONOSCOPY; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; DISEASE ACTIVITY; DISEASE DURATION; DRUG MEGADOSE; DRUG SAFETY; ENTERITIS; ERYTHROCYTE SEDIMENTATION RATE; HIGH RISK PATIENT; HUMAN; INTESTINE FISTULA; INTESTINE PERFORATION; INTESTINE RESECTION; NOTE; PATIENT CODING; PREDICTION; RATING SCALE; RECURRENT DISEASE; RISK FACTOR; SMOKING CESSATION;

EID: 79954567937     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (7)

1. Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology. 1990;99:956-963. (Pubitemid 20338451)
2. Hanauer SB, Korelitz BI, Rutgeerts P, et al. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology. 2004;127:723-729. (Pubitemid 39208405)
3. Rutgeerts P, Van Assche G, Vermeire S, et al. Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology. 2005;128:856-861. (Pubitemid 40523538)
4. D'Haens GR, Vermeire S, Van Assche G, et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial. Gastroenterology. 2008;135:1123-1129.
5. Regueiro M. Management and prevention of postoperative Crohn's disease. Inflamm Bowel Dis. 2009;15:1583-1590.
6. Regueiro M, Schraut W, Baidoo L, et al. Infliximab prevents Crohn's disease recurrence after ileal resection. Gastroenterology. 2009;136:441-450; quiz 716.
7. Regueiro M, Kip KE, Schraut W, et al. Crohn's disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resection. Inflamm Bowel Dis. 2011;17:118-126.